Stuart Thomson

4.9k total citations · 1 hit paper
55 papers, 3.7k citations indexed

About

Stuart Thomson is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Stuart Thomson has authored 55 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 16 papers in Oncology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Stuart Thomson's work include Ubiquitin and proteasome pathways (9 papers), Lung Cancer Treatments and Mutations (6 papers) and Micro and Nano Robotics (5 papers). Stuart Thomson is often cited by papers focused on Ubiquitin and proteasome pathways (9 papers), Lung Cancer Treatments and Mutations (6 papers) and Micro and Nano Robotics (5 papers). Stuart Thomson collaborates with scholars based in United Kingdom, United States and Germany. Stuart Thomson's co-authors include John D. Haley, Louis C. Mahadevan, Alison L. Clayton, Filippo Petti, Neil W. Gibson, Elizabeth Buck, Kenneth K. Iwata, David Epstein, Eric Brown and Graeme Griffin and has published in prestigious journals such as The EMBO Journal, Blood and Molecular Cell.

In The Last Decade

Stuart Thomson

54 papers receiving 3.7k citations

Hit Papers

Epithelial to Mesenchymal Transition Is a Determinant of ... 2005 2026 2012 2019 2005 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stuart Thomson United Kingdom 25 2.1k 1.2k 696 511 313 55 3.7k
Chris van Bree Netherlands 18 2.3k 1.1× 1.2k 1.0× 622 0.9× 793 1.6× 245 0.8× 47 4.4k
Hongjuan Zhao United States 37 2.2k 1.0× 795 0.7× 915 1.3× 886 1.7× 393 1.3× 97 4.2k
Honnavara N. Ananthaswamy United States 35 2.0k 0.9× 1.3k 1.1× 531 0.8× 498 1.0× 665 2.1× 76 5.0k
Diane Braguer France 39 2.3k 1.1× 1.1k 0.9× 486 0.7× 536 1.0× 1.1k 3.6× 104 4.6k
Hang Zhang China 40 2.9k 1.4× 1.2k 1.0× 335 0.5× 856 1.7× 236 0.8× 228 5.9k
Zhiyong Wang China 39 3.1k 1.4× 1.1k 0.9× 418 0.6× 645 1.3× 652 2.1× 145 5.2k
Gareth M. Watkins United Kingdom 41 2.6k 1.2× 1.7k 1.4× 293 0.4× 1.1k 2.1× 379 1.2× 126 5.2k
Wen Xu China 32 1.8k 0.9× 1.1k 0.9× 672 1.0× 747 1.5× 156 0.5× 157 4.2k
Peter M. Corry United States 38 1.8k 0.8× 459 0.4× 818 1.2× 414 0.8× 397 1.3× 157 4.7k

Countries citing papers authored by Stuart Thomson

Since Specialization
Citations

This map shows the geographic impact of Stuart Thomson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart Thomson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart Thomson more than expected).

Fields of papers citing papers by Stuart Thomson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart Thomson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart Thomson. The network helps show where Stuart Thomson may publish in the future.

Co-authorship network of co-authors of Stuart Thomson

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart Thomson. A scholar is included among the top collaborators of Stuart Thomson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart Thomson. Stuart Thomson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Devauchelle, Olivier, et al.. (2024). On wave-driven propulsion. Journal of Fluid Mechanics. 987. 2 indexed citations
2.
Thomson, Stuart, et al.. (2023). Bidirectional wave-propelled capillary spinners. Communications Physics. 6(1). 6 indexed citations
3.
Clark, Kristopher, Edward Ainscow, Stuart Thomson, et al.. (2017). CT7001, a Novel Orally Bio-Available CDK7 Inhibitor, Is Highly Active in in-Vitro and in-Vivo Models of AML. Blood. 130. 2645–2645. 15 indexed citations
4.
Thomson, Stuart & P. D. Howell. (2016). A model for extreme plasticity. Journal of the Mechanics and Physics of Solids. 94. 362–371.
5.
Lin, Yi‐Chun, et al.. (2014). The RON Receptor Tyrosine Kinase Promotes Metastasis by Triggering MBD4-Dependent DNA Methylation Reprogramming. Cell Reports. 6(1). 141–154. 39 indexed citations
6.
Thomson, Stuart, Elizabeth Buck, Erica Ullman, et al.. (2012). Abstract B56: Insights into the role of Epithelial to Mesenchymal transition (EMT) as an important mechanism of drug-resistance to molecular targeted therapies. Clinical Cancer Research. 18(10_Supplement). B56–B56. 1 indexed citations
7.
Thomson, Stuart, et al.. (2008). Kinase switching in mesenchymal-like non-small cell lung cancer lines contributes to EGFR inhibitor resistance through pathway redundancy. Clinical & Experimental Metastasis. 25(8). 843–854. 156 indexed citations
8.
Buck, Elizabeth, Alexandra Eyzaguirre, Maryland Rosenfeld-Franklin, et al.. (2008). Feedback Mechanisms Promote Cooperativity for Small Molecule Inhibitors of Epidermal and Insulin-Like Growth Factor Receptors. Cancer Research. 68(20). 8322–8332. 164 indexed citations
9.
Barr, Sharon, Stuart Thomson, Elizabeth Buck, et al.. (2008). Bypassing cellular EGF receptor dependence through epithelial-to-mesenchymal-like transitions. Clinical & Experimental Metastasis. 25(6). 685–693. 169 indexed citations
10.
Barr, Sharon, Suzanne Russo, Elizabeth Buck, et al.. (2007). The EGFR antagonist, erlotinib, combined with a small molecule inhibitor of IGF-1R acts synergistically to inhibit proliferation and induce apoptosis in ovarian and HNSCC cells. Molecular Cancer Therapeutics. 6. 3 indexed citations
11.
Buck, Elizabeth, Alexandra Eyzaguirre, Stuart Thomson, et al.. (2007). Differential effects for small molecule versus antibody inhibitors of EGFR: Erlotinib, but not the neutralizing antibody C225, achieves inhibition of the EGFR-HER3-Akt signaling cascade. Molecular Cancer Therapeutics. 6. 1 indexed citations
12.
Mahadevan, Louis C., Alison L. Clayton, Catherine A. Hazzalin, & Stuart Thomson. (2004). Phosphorylation and Acetylation of Histone H3 at Inducible Genes: Two Controversies Revisited. Novartis Foundation symposium. 259. 102–114. 19 indexed citations
13.
Thomson, Stuart, et al.. (2004). Heat Shock, Histone H3 Phosphorylation and the Cell Cycle. Cell Cycle. 4(1). 13–17. 11 indexed citations
14.
Shear, Neil H., et al.. (2002). Mechanism of Impila (Callilepis laureola)-induced cytotoxicity in Hep G2 cells. Clinical Biochemistry. 35(1). 57–64. 17 indexed citations
15.
Thomson, Stuart, Alison L. Clayton, & Louis C. Mahadevan. (2001). Independent Dynamic Regulation of Histone Phosphorylation and Acetylation during Immediate-Early Gene Induction. Molecular Cell. 8(6). 1231–1241. 176 indexed citations
16.
Shear, Neil H., Izabella M. Malkiewicz, Michael J. Stewart, et al.. (2001). The toxicity of Callilepis laureola, a South African traditional herbal medicine. Clinical Biochemistry. 34(3). 229–236. 67 indexed citations
18.
Sibille, Catherine, Keith G. Gould, Stuart Thomson, et al.. (1995). LMP2+ proteasomes are required for the presentation of specific antigens to cytotoxic T lymphocytes. Current Biology. 5(8). 923–930. 86 indexed citations
19.
Thomson, Stuart, et al.. (1993). cDNA cloning of a new type of subunit of mammalian proteasomes. FEBS Letters. 322(2). 135–138. 16 indexed citations
20.
Sweeney, Sean T., et al.. (1992). Enhanced Levels of Multicatalytic Proteinase mRNAs in Rous Sarcoma Virus Transformed Cells. Biological Chemistry Hoppe-Seyler. 373(2). 623–628. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026